Infection of total hip replacement is a disaster, with a quoted incidence of 1-2%. Anecdotal evidence has led many to believe that aggressive management of early infection following hip replacement can prevent failure. As yet, there is no firm evidence. We have reviewed 20 consecutive cases of early infection (<6 weeks post-op) treated by open debridement and washout.

The cases were 19 total hip replacements and 1 hemiarthroplasty. All had prolonged wound I discharge and elevated inflammatory parameters. No differentiation was made between superficial and deep infections because at this stage the deep fascia had not yet healed. 13 cases had positive cultures (6 staphylococcus, 5 coagulase negative staphylococcus, 1 coliform, 1 streptococcus). 7 cases had either negative cultures or mixed growth, but were clinically infected. Intravenous antibiotics were given after debridement until the wound healed.

Thirteen (65%) were clinically and radiologically free of infection at a minimum of 1 year follow-up. Failure to eradicate infection was treated by revision surgery and this was performed in 4 patients. Of the remaining 3 patients, one underwent excision arthroplasty, one was infected but refused surgery and one was infected but medically unfit for surgery. There is no control group, but it would be ethically very difficult to organise. As expected, we had small numbers and a mixed collection of organisms, so statistical comparisons are limited.

In conclusion, these patients represent a very high risk of ongoing infection. 13 hips (65%) had no evidence of ongoing infection at a minimum of 1 year follow up. This study supports aggressive surgical management of early infection following hip replacements. Eradication of early infection can be achieved without removal of the implant.